DFTX · earnings call history
Definium Therapeutics Q2 FY26 — Positive Phase III MDD Results & Upcoming GAD Data
Read the briefDefinium Therapeutics Q4 FY25 — Pivotal Phase III Readouts Imminent for DT120 ODT
Read the briefBrowse all US companies on the earnings-call register.